Vimarsana
Biggest News Aggregation in the World

Page 14 - Mark Lemley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Lemley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Lemley Today - Breaking & Trending Today

Liberal Supreme Court justices shouldn't let Clarence Thomas off the hook - Vimarsana News

Liberal Supreme Court justices shouldn't let Clarence Thomas off the hook

Justices Ketanji Brown Jackson, Sonia Sotomayor and Elena Kagan are letting their love of the Supreme Court blind them to its problems.

Source: msnbc.com
Fish & Richardson Cashes in as Big Tech's Go-To Trial Law Firm - Vimarsana News

Fish & Richardson Cashes in as Big Tech's Go-To Trial Law Firm

Fish & Richardson’s role as top trial lawyers for big tech companies helped the century-old firm bring in record revenue last year. The firm represented major tech companies in 52 federal lawsuits over the year, the most of any law firm, according to a Bloomberg Law analysis. Most of those cases were for Apple Inc.

Drugmakers take sides in Amgen, Regeneron fight over antibody patents - Vimarsana News

Drugmakers take sides in Amgen, Regeneron fight over antibody patents

BioPharma

Court concerned about scope of patent covering millions of antibodies - Vimarsana News

Court concerned about scope of patent covering millions of antibodies

During oral argument in Amgen Inc. v. Sanofi on Monday, the justices explored how to write an opinion on patent enablement when the parties agree on almost everything about the legal standard. “Enablement” is the requirement that a patent must enable others to make and use the invention without un

GlaxoSmithKline Files Amicus Brief in Amgen v. Sanofi | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

GlaxoSmithKline Files Amicus Brief in Amgen v. Sanofi | McDonnell Boehnen Hulbert & Berghoff LLP

The Supreme Court's decision to grant certiorari in Amgen v. Sanofi is the first time in almost a hundred years that the Court has deigned to consider sufficiency of disclosure...